These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11913728)

  • 21. The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels.
    Kerb R; Aynacioglu AS; Brockmöller J; Schlagenhaufer R; Bauer S; Szekeres T; Hamwi A; Fritzer-Szekeres M; Baumgartner C; Ongen HZ; Güzelbey P; Roots I; Brinkmann U
    Pharmacogenomics J; 2001; 1(3):204-10. PubMed ID: 11908757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.
    Zhou SF
    Xenobiotica; 2008 Jul; 38(7-8):802-32. PubMed ID: 18668431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy.
    Brinkmann U; Roots I; Eichelbaum M
    Drug Discov Today; 2001 Aug; 6(16):835-839. PubMed ID: 11495756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The MDR1 3435 polymorphism in patients with rheumatoid arthritis.
    Pawlik A; Wrzesniewska J; Fiedorowicz-Fabrycy I; Gawronska-Szklarz B
    Int J Clin Pharmacol Ther; 2004 Sep; 42(9):496-503. PubMed ID: 15487808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes.
    Oselin K; Gerloff T; Mrozikiewicz PM; Pähkla R; Roots I
    Fundam Clin Pharmacol; 2003 Aug; 17(4):463-9. PubMed ID: 12914549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of functional MDR1 gene polymorphisms on P-glycoprotein activity in CD34+ hematopoietic stem cells.
    Calado RT; Falcão RP; Garcia AB; Gabellini SM; Zago MA; Franco RF
    Haematologica; 2002 Jun; 87(6):564-8. PubMed ID: 12031911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
    Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
    Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, molecular structure, and validation of metalloprobes for assessment of MDR1 P-glycoprotein-mediated functional transport.
    Sivapackiam J; Harpstrite SE; Prior JL; Gu H; Rath NP; Sharma V
    Dalton Trans; 2010 Jul; 39(25):5842-50. PubMed ID: 20505882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDR1 gene polymorphisms and clinical relevance.
    Li YH; Wang YH; Li Y; Yang L
    Yi Chuan Xue Bao; 2006 Feb; 33(2):93-104. PubMed ID: 16529292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells.
    Hitzl M; Drescher S; van der Kuip H; Schäffeler E; Fischer J; Schwab M; Eichelbaum M; Fromm MF
    Pharmacogenetics; 2001 Jun; 11(4):293-8. PubMed ID: 11434506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDR1 genetic polymorphism does not modify either cell permissiveness to HIV-1 or disease progression before treatment.
    Bleiber G; May M; Suarez C; Martinez R; Marzolini C; Egger M; Telenti A;
    J Infect Dis; 2004 Feb; 189(4):583-6. PubMed ID: 14767809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects.
    Pauli-Magnus C; Feiner J; Brett C; Lin E; Kroetz DL
    Clin Pharmacol Ther; 2003 Nov; 74(5):487-98. PubMed ID: 14586389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of multidrug resistance-associated protein (MRP) expression in multidrug resistance.
    Kavallaris M
    Anticancer Drugs; 1997 Jan; 8(1):17-25. PubMed ID: 9147606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Steroid and xenobiotic receptor (SXR), multidrug resistance gene (MDR1) and GSTs, SULTs and CYP polymorphism expression in invasive bladder cancer, analysis of their expression and correlation with other prognostic factors].
    Rioja Zuazu J; Bandrés Elizalde E; Rosell Costa D; Rincón Mayans A; Zudaire Bergera J; Gil Sanz MJ; Rioja Sanz LA; García Foncillas J; Berián Polo JM
    Actas Urol Esp; 2007; 31(10):1107-16. PubMed ID: 18314648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier.
    Sharma V; Prior JL; Belinsky MG; Kruh GD; Piwnica-Worms D
    J Nucl Med; 2005 Feb; 46(2):354-64. PubMed ID: 15695797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.
    Barthomeuf C; Demeule M; Grassi J; Saidkhodjaev A; Beliveau R
    Planta Med; 2006 Jun; 72(7):634-9. PubMed ID: 16739070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.
    Droździk M; Białecka M; Myśliwiec K; Honczarenko K; Stankiewicz J; Sych Z
    Pharmacogenetics; 2003 May; 13(5):259-63. PubMed ID: 12724617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of multidrug transporter-mediated efflux of avermectins in human and mouse neuroblastoma cell lines.
    Dalzell AM; Mistry P; Wright J; Williams FM; Brown CD
    Toxicol Lett; 2015 Jun; 235(3):189-98. PubMed ID: 25865432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity.
    Ameyaw MM; Regateiro F; Li T; Liu X; Tariq M; Mobarek A; Thornton N; Folayan GO; Githang'a J; Indalo A; Ofori-Adjei D; Price-Evans DA; McLeod HL
    Pharmacogenetics; 2001 Apr; 11(3):217-21. PubMed ID: 11337937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin.
    Chen WS; Luker KE; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
    Biochem Pharmacol; 2000 Aug; 60(3):413-26. PubMed ID: 10856437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.